Table 1.

28-Day all-cause mortality in TFPI-treated and placebo-treated patients

	Overall
INR ≥1.2	Placebo	TFPI	P
Positive blood culture
n	257	278
Total (%)	29.4	31.6	0.054
Mortality (%)	35.4	27.7
Positive other
n	387	370
Total (%)	44.3	42.0	0.94
Mortality (%)	35.1	35.4
Negative culture/not done
n	230	232
Total (%)	26.3	26.4	0.02
Mortality (%)	30.0	40.1

Presented are 28-day all-cause mortality rates in TFPI and placebo-treated patients with positive blood cultures, other documented infections, and negative culture or undocumented infections. INR, international normalized ratio; TFPI, Tissue factor pathway inhibitor.